Yahoo

Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy

Trade NMRA on Coinbase

Neumora Therapeutics, Inc. (NASDAQ: NMRA ) is among the best get rich quick stocks to buy right now . On June 18, Mizuho lowered the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $4, down from $6. This came after the company's negative Phase 3 KOASTAL-2 and -3 study outcomes. The firm has now removed navacaprant for depression from its financial model.

While highlighting the company's pipeline, Mizuho reiterated an Outperform rating on Neumora Therapeutics, Inc. (NASDAQ:NMRA). Although still in early stages, the pipeline is "highly intriguing," the analyst said. The company is developing NMRA-511, which is currently in Phase 1b clinical trials for Alzheimer's disease agitation, as well as NMRA-861 and NMRA-898.

Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration

Copyright: dolgachov / 123RF Stock Photo

The firm's model incorporates contributions from the clinical-stage assets. With that said, Mizuho anticipates critical updates for each program in the latter half of this year. The Street projects an upside potential of 199.40% for Neumora Therapeutics, Inc. (NASDAQ:NMRA), making it one of the best get rich quick stocks to buy right now.

The company also saw price cuts from two other firms. On June 16, Needham trimmed the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $5 from $8 and reaffirmed a Buy rating. On the same day, H.C. Wainwright also reduced the price target on the company from $18 to $7. The firm maintained a Buy rating.

Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a Massachusetts-based clinical-stage biopharmaceutical company that develops therapeutic solutions for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases.

While we acknowledge the potential of NMRA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years

Disclosure: None. Follow Insider Monkey on Google News .

Mobilize your Website
View Site in Mobile | Classic
Share by: